Multisystem late onset Pompe disease (LOPD): an update on clinical aspects

Annals of Translational Medicine
A ToscanoO Musumeci

Abstract

Pompe disease is classified by age of onset, organ involvement, severity, and rate of progression in two main forms: the first one, infantile onset Pompe disease (IOPD), presents before the age of 12 months with generalized muscle weakness, hypotonia, respiratory distress, and hypertrophic cardiomyopathy as main clinical features. The second form, late onset Pompe disease (LOPD), is characterized by an onset at the age of 12 months to adulthood, hyperCKemia, and limb-girdle and axial muscle weakness, often complicated by respiratory muscles degeneration. In the last 10-15 years, an increasing interest in Pompe disease has led to multiple studies in an effort to clarify the emerging clinical aspects, to find out the best diagnostic tools to identify the disease as early as possible, and to offer new therapeutic options apart from enzyme replacement therapy (ERT). Since 2006, ERT-the first treatment for Pompe disease-has been universally accepted in the majority of countries all over the world. Although for years Pompe disease has been primarily considered a muscle disorder, nowadays it is clear that the involvement of several other organs has changed the cultural approach to this entity which is now viewed as a multisystem disor...Continue Reading

Citations

Aug 4, 2020·Aging·Simona TavernaGiovanni Duro
Sep 18, 2020·Expert Review of Neurotherapeutics·Corrado AngeliniSabrina Sacconi
Sep 24, 2020·Biomolecules·Naresh K Meena, Nina Raben
Aug 11, 2020·Journal of Neuromuscular Diseases·Jens Reimann, Cornelia Kornblum
Mar 13, 2020·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Paolo RuggeriAntonio Toscano
Apr 7, 2020·Orphanet Journal of Rare Diseases·P VanherpeK G Claeys
Oct 18, 2020·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Enricomaria MorminaAntonio Toscano
Dec 17, 2020·Journal of Inherited Metabolic Disease·Anna SidorinaCarlo Dionisi-Vici
Jan 3, 2021·Neuromuscular Disorders : NMD·H A van KootenP A van Doorn
Nov 20, 2020·Internal Medicine Journal·Heidi PetersJeff Szer
Feb 17, 2021·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Francesca CarubbiUNKNOWN Italian Society of Human Nutrition Working Group on Nutrition in Lysosomal Storage Diseases
Jul 17, 2020·Molecular Therapy. Methods & Clinical Development·Naresh Kumar MeenaRosa Puertollano
May 3, 2021·Orphanet Journal of Rare Diseases·Shanquan ChenDong Dong
May 23, 2021·Orphanet Journal of Rare Diseases·Paula Hernández-ArévaloHada C Macher
Nov 6, 2021·Nature Communications·Helena Costa-VerderaFederico Mingozzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

© 2021 Meta ULC. All rights reserved